Characterization of the gene expression profile of neuroblastoma cell line IMR-5 using serial analysis of gene expression

Cancer Letters

Volumn 190, Issue 1, 2003, Pages 79-87

  Fischer, Matthias ^a   Berthold, Frank ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Cell line; Gene expression profile; MYCN; Neuroblastoma; Serial analysis of gene expression

Indexed keywords

ARTICLE; CANCER CELL CULTURE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

SALVIA;

EID: 0037428894     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00581-5     Document Type: Article

References (27)

1. Castleberry R.P. Neuroblastoma. Eur. J. Cancer. 33:1997;1430-1438.
2. Maris J.M., Matthay K.K. Molecular biology of neuroblastoma. J. Clin. Oncol. 17:1999;2264-2279.
3. Ambros P.F., Brodeur G.M. Concept of tumorigenesis and regression. Brodeur G.M., Sawada T., Tsuchida Y., Voute P.A. Neuroblastoma. 2000;21-32 Elsevier Science, Amsterdam.
4. Velculescu V.E., Zhang L., Vogelstein B., Kinzler K.W. Serial analysis of gene expression. Science. 270:1995;484-487.
5. Velculescu V.E., Zhang L., Zhou W., Vogelstein J., Basrai M.A., Bassett D.E. Jr., Hieter P., Vogelstein B., Kinzler K.W. Characterization of the yeast transcriptome. Cell. 88:1997;243-251.
6. Tumilowicz J.J., Nichols W.W., Cholon J.J., Greene A.E. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res. 30:1970;2110-2118.
7. Bukovsky J., Evans A., Tartaglione M., Kennett R.H. Selection of variant neuroblastoma cell line which has lost cell surface expression of antigen detected by monoclonal antibody PI153/3. Somat. Cell Mol. Genet. 11:1985;517-522.
8. Alon U., Barkai N., Notterman D.A., Gish K., Ybarra S., Mack D., Levine A.J. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. USA. 96:1999;6745-6750.
9. Zhang L., Zhou W., Velculescu V.E., Kern S.E., Hruban R.H., Hamilton S.R., Vogelstein B., Kinzler K.W. Gene expression profiles in normal and cancer cells. Science. 276:1997;1268-1272.
10. Powell J. Enhanced concatemer cloning - a modification to the SAGE (serial analysis of gene expression) technique. Nucleic Acids Res. 26:1998;3445-3446.
11. Stevenson R.J., Hamilton S.J., MacCallum D.E., Hall P.A., Fuller-Pace F.V. Expression of the 'DEAD box' RNA helicase p68 is developmentally and growth regulated and correlates with organ differentiation/maturation in the fetus. J. Pathol. 184:1998;351-359.
12. Eschenfeldt W.H., Berger S.L. The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA. Proc. Natl. Acad. Sci. USA. 83:1986;9403-9407.
13. Melhem R.F., Strahler J.R., Hailat N., Zhu X.X., Hanash S.M. Involvement of OP18 in cell proliferation. Biochem. Biophys. Res. Commun. 179:1991;1649-1655.
14. Lin S.C., Morrison-Bogorad M. Developmental expression of mRNAs encoding thymosins beta 4 and beta 10 in rat brain and other tissues. J. Mol. Neurosci. 2:1990;35-44.
15. Pahlman S., Hedborg F. Development of the neural crest and sympathetic nervous system. Brodeur G.M., Sawada T., Tsuchida Y., Voute P.A. Neuroblastoma. 2000;9-19 Elsevier Science, Amsterdam.
16. Boon K., Caron H.N., van Asperen R., Valentijn L., Hermus M.C., van Sluis P., Roobeek I., Weis I., Voute P.A., Schwab M., Versteeg R. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J. 20:2001;1383-1393.
17. Godfried M.B., Veenstra M., v Sluis P., Boon K., v Asperen R., Hermus M.C., v Schaik B.D., Voute T.P., Schwab M., Versteeg R., Caron H.N. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene. 21:2002;2097-2101.
18. Squire J.A., Thorner P.S., Weitzman S., Maggi J.D., Dirks P., Doyle J., Hale M., Godbout R. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Oncogene. 10:1995;1417-1422.
19. Jones T.A., Flomen R.H., Senger G., Nizetic D., Sheer D. The homeobox gene MEIS1 is amplified in IMR-32 and highly expressed in other neuroblastoma cell lines. Eur. J. Cancer. 36:2000;2368-2374.
20. Spieker N., van Sluis P., Beitsma M., Boon K., van Schaik B.D., van Kampen A.H., Caron H., Versteeg R. The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32. Genomics. 71:2001;214-221.
21. Wimmer K., Zhu X.X., Lamb B.J., Kuick R., Ambros P.F., Kovar H., Thoraval D., Motyka S., Alberts J.R., Hanash S.M. Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma. Oncogene. 18:1999;233-238.
22. Manohar C.F., Salwen H.R., Brodeur G.M., Cohn S.L. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma. Genes Chromosomes Cancer. 14:1995;196-203.
23. Audic S., Claverie J.M. The significance of digital gene expression profiles. Genome Res. 7:1997;986-995.
24. Virlon B., Cheval L., Buhler J.M., Billon E., Doucet A., Elalouf J.M. Serial microanalysis of renal transcriptomes. Proc. Natl. Acad. Sci. USA. 96:1999;15286-15291.
25. Yamamoto M., Wakatsuki T., Hada A., Ryo A. Use of serial analysis of gene expression (SAGE) technology. J. Immunol. Methods. 250:2001;45-66.
26. Savelyeva L., Schwab M. Amplification of oncogenes revisited: from expression profiling to clinical application. Cancer Lett. 167:2001;115-123.
27. Welle S., Bhatt K., Thornton C.A. Inventory of high-abundance mRNAs in skeletal muscle of normal men. Genome Res. 9:1999;506-513.